Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 3/8/2019 |
| Start Date: | September 15, 2008 |
| End Date: | October 25, 2016 |
Understanding the Anatomy and Physiology of the Sensory Experience and Its Role in Generating Tics in Tourette Syndrome
This study will investigate the sensation that many people with Tourette syndrome (TS)
experience before they have a motor tic. It will also test whether blocking the sensation
causes the tic to stop.
People between 18 and 65 years of age with TS who have at least once tic involving an arm may
be eligible for this 3-part study. Those enrolled may participate in all parts or in part 1
or part 2. Those who choose to participate in part 3 must first complete part 2. All must
stop taking medication for TS and any other medication that may affect the brain for at least
1 week before the study.
Part 1
After numbing the skin or muscles of the arm or leg where a pre-tic sensation is experienced,
the response of the nerves will be tested by asking subjects to rate the strength of the
sensation after a pinprick and by stimulating the nerves with small electrical shocks. Then,
over the course of approximately one hour, subjects will report pre-tic sensations while
their motor tics are counted. The onset of each tic will be identified with EMG, a test using
electrodes on the skin to indicate the activity of the muscles.
Part 2
Subjects brain waves are recorded using magnetoencephalography (MEG) while they are
experiencing tics andpre-tic sensory experiences. MEG is a test that records magnetic field
changes produced by brain activity. Subjects sit in a chair under a dome containing magnetic
field detectors. They watch a clock and report the time a sensory experience starts. Tics are
recorded with EMG. Later, a standard MRI of the brain (scan using a magnetic field and radio
waves) is done to see which parts of the brain produced the activity recorded with MEG.
Part 3
Repetitive transcranial magnetic stimulation (rTMS) is used to try to stop the pre-tic
sensations. For TMS, the subject sits in a chair. A wire coil is held on the subject s scalp,
and a brief electrical current is passed through the coil, creating a magnetic pulse that
stimulates a region of the brain. The goal of this stimulation is to reduce the sensory
experience that precedes a tic in one region of the body. During stimulation, the subject
hears a click and may feel a pulling sensation on the skin under the coil. There may be a
twitch in the muscles of the face, arm or leg. This study uses a pattern of repeated pulses
delivered in short bursts. Following each train of pulses, the effect of the stimulation on
sensation will be tested by asking the subject to rate the strength of a pinprick and of a
vibration. In addition, the nerves are stimulated with small shocks to evaluate the effect of
the TMS on nerve activity. To determine the effect of TMS on the pre-tic sensation, subjects
are asked to watch a clock and report when they are having a sensory experience. The effect
on motor tics will be evaluated by using EMG to indicate the tics.
experience before they have a motor tic. It will also test whether blocking the sensation
causes the tic to stop.
People between 18 and 65 years of age with TS who have at least once tic involving an arm may
be eligible for this 3-part study. Those enrolled may participate in all parts or in part 1
or part 2. Those who choose to participate in part 3 must first complete part 2. All must
stop taking medication for TS and any other medication that may affect the brain for at least
1 week before the study.
Part 1
After numbing the skin or muscles of the arm or leg where a pre-tic sensation is experienced,
the response of the nerves will be tested by asking subjects to rate the strength of the
sensation after a pinprick and by stimulating the nerves with small electrical shocks. Then,
over the course of approximately one hour, subjects will report pre-tic sensations while
their motor tics are counted. The onset of each tic will be identified with EMG, a test using
electrodes on the skin to indicate the activity of the muscles.
Part 2
Subjects brain waves are recorded using magnetoencephalography (MEG) while they are
experiencing tics andpre-tic sensory experiences. MEG is a test that records magnetic field
changes produced by brain activity. Subjects sit in a chair under a dome containing magnetic
field detectors. They watch a clock and report the time a sensory experience starts. Tics are
recorded with EMG. Later, a standard MRI of the brain (scan using a magnetic field and radio
waves) is done to see which parts of the brain produced the activity recorded with MEG.
Part 3
Repetitive transcranial magnetic stimulation (rTMS) is used to try to stop the pre-tic
sensations. For TMS, the subject sits in a chair. A wire coil is held on the subject s scalp,
and a brief electrical current is passed through the coil, creating a magnetic pulse that
stimulates a region of the brain. The goal of this stimulation is to reduce the sensory
experience that precedes a tic in one region of the body. During stimulation, the subject
hears a click and may feel a pulling sensation on the skin under the coil. There may be a
twitch in the muscles of the face, arm or leg. This study uses a pattern of repeated pulses
delivered in short bursts. Following each train of pulses, the effect of the stimulation on
sensation will be tested by asking the subject to rate the strength of a pinprick and of a
vibration. In addition, the nerves are stimulated with small shocks to evaluate the effect of
the TMS on nerve activity. To determine the effect of TMS on the pre-tic sensation, subjects
are asked to watch a clock and report when they are having a sensory experience. The effect
on motor tics will be evaluated by using EMG to indicate the tics.
Objectives:
We will investigate whether the sensory experience that precedes motor tics in Tourette
syndrome is generated in the peripheral nervous system and whether it may result from altered
sensory gating, and whether it is necessary to generate motor tics.
Study Population:
We will study 100 subjects. Thirty-five individuals with a diagnosis of Tourette syndrome who
can describe a sensory experience preceding their tics, and 10 who deny a sensory prodrome
for a total of 45 subjects. We will also study 55 Healthy volunteers ages 18-65..
Design: A Two-Part Study
Part I: MEG recording
We will determine the extent to which CNS responses to tactile and auditory stimuli
habituate. Subjects will be presented with trains of stimuli, repeated 80 times. At the end
of each of these blocks, a questionnaire will ascertain the subject s perception of these
stimuli. CNS responses to the stimuli will be recorded using MEG and analyzed first for
localization, and then for amplitude and frequency characteristics. Healthy volunteers will
be included as a control group.
Part II: rTMS inhibition
We will test whether the sensory experience is necessary for generating a motor tic. We will
inhibit the sensory experience using repetitive transcranial magnetic stimulation (rTMS) over
the cortical region identified by prior and ongoing imaging studies in our group. Low
intensity rTMS will be applied as a control. Sensory experiences and motor tics will be
recorded before and after rTMS..
Staged Study:
This will be a staged, exploratory study. In phase 1, we will study 20 adult subjects for
part II. Data analysis of this phase will determine whether the procedures are well-tolerated
and safe enough to allow for the inclusion of adolescent children, ages 14 and older. Phase 2
will involve completion of both parts, with 20 subjects each.
Outcome Measures:
For part II, the outcome measures will be 1) inhibition of the sensory experience, and 2) the
relationship between inhibition of sensory and motor phenomena. For part I, the outcome
measure will be degree of habituation in TS subjects as compared to that in healthy
volunteers.
We will investigate whether the sensory experience that precedes motor tics in Tourette
syndrome is generated in the peripheral nervous system and whether it may result from altered
sensory gating, and whether it is necessary to generate motor tics.
Study Population:
We will study 100 subjects. Thirty-five individuals with a diagnosis of Tourette syndrome who
can describe a sensory experience preceding their tics, and 10 who deny a sensory prodrome
for a total of 45 subjects. We will also study 55 Healthy volunteers ages 18-65..
Design: A Two-Part Study
Part I: MEG recording
We will determine the extent to which CNS responses to tactile and auditory stimuli
habituate. Subjects will be presented with trains of stimuli, repeated 80 times. At the end
of each of these blocks, a questionnaire will ascertain the subject s perception of these
stimuli. CNS responses to the stimuli will be recorded using MEG and analyzed first for
localization, and then for amplitude and frequency characteristics. Healthy volunteers will
be included as a control group.
Part II: rTMS inhibition
We will test whether the sensory experience is necessary for generating a motor tic. We will
inhibit the sensory experience using repetitive transcranial magnetic stimulation (rTMS) over
the cortical region identified by prior and ongoing imaging studies in our group. Low
intensity rTMS will be applied as a control. Sensory experiences and motor tics will be
recorded before and after rTMS..
Staged Study:
This will be a staged, exploratory study. In phase 1, we will study 20 adult subjects for
part II. Data analysis of this phase will determine whether the procedures are well-tolerated
and safe enough to allow for the inclusion of adolescent children, ages 14 and older. Phase 2
will involve completion of both parts, with 20 subjects each.
Outcome Measures:
For part II, the outcome measures will be 1) inhibition of the sensory experience, and 2) the
relationship between inhibition of sensory and motor phenomena. For part I, the outcome
measure will be degree of habituation in TS subjects as compared to that in healthy
volunteers.
- INCLUSION CRITERIA:
Tourette subjects must be 18-65 years of age of any race, gender, or handedness. They must
be able to sit for at least 2 hours and remain at the testing site for up to 8 hours. They
must be able to follow instructions and participate in reporting sensory experiences. The
upper extremity tic to be studied must occur at least once a minute, but no more frequently
than once every 5 seconds. Individuals with comorbid attention deficit disorder (ADD or
ADHD) or with obsessive-compulsive disorder (OCD) will not be excluded.
Healthy volunteers must be 18-65 years of age, of any race, gender, or handedness.
EXCLUSION CRITERIA:
1. Inability to stop taking all central-acting medications, including those used to treat
tics, for at least one week prior to the study
2. Current use of coumadin, heparin, or lovenox
3. Any additional movement disorder, including tremor, myoclonus, or dystonia
4. A diagnosis of major depression or bipolar disorder
5. Frequent or severe headaches
6. Any history of or current experience of hallucinations
7. Any history of a seizure or epilepsy or a family history of epilespy
8. Any prior brain injury, brain tumor or other lesion, stroke, or surgery
9. A diagnosis of increased intracranial pressure
10. A history of significant heart disease
11. Any history of hearing problems, or abnormal results on auditory testing (part I or
II)
12. Any of the following: pacemakers or other implanted electrical devices, brain
stimulators, dental implants, aneurysm clips (metal clips on the wall of a large
artery), metallic prostheses (including metal pins and rods, heart valves, and
cochlear implants), permanent eyeliner, implanted delivery pump, or shrapnel fragments
(part I and II only)
13. Any history of work as a welder or metal worker (part I and II)
14. Current pregnancy
15. Tobacco use (cigarette, chewing, or other) in the month prior to the study (part II)
16. Diagnosis of, treatment for, or self-report of alcohol abuse (alcoholism) (part I)
17. Cocaine use in the year prior to involvement in the study (part I)
18. Use of any medication within one month prior to the study with cholinergic or
anticholinergic properties, including (but not limited to): nicotine patch, nicorette
gum, atrovent, enablex, toriaz, ditropan, vesicare, detrol, sanctura, artane, Aricept,
cogentin, akineton, zanaflex, norflex, flexeril, lomotil, mototen, levsin, razadyne,
exelon (part I)
19. Peripheral neuropathy or carpal tunnel syndrome (part I)
20. Inability to hold head still for 10 minutes (part I).
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials
